Drugs (ATC group) | Total n(%) | Proportion of co-users | p-valueA |
---|---|---|---|
Against gastrointestinal conditions (A01-09) | 15 (6) | 60% | 0.288 |
Analgesics (M01A, N02B) | 55 (23) | 58% | 0.031 B |
Anti-infectives (G01, J01-05) | 2 (1) | 50% | 1.000 |
Anticoagulants (B01) | 88 (37) | 36% | 0.043 B |
Antidepressants (N06) | 20 (8) | 50% | 0.815 |
Antidiabetics (A10) | 23 (10) | 52% | 0.515 |
Antihistamines (R06) | 25 (10) | 32% | 0.204 |
Antihyperlipidemic agents (C10) | 81 (34) | 47% | 0.784 |
Antihypertensives and diuretics (C02-C03, C07-09) | 107 (45) | 45% | 1.000 |
Anti-menopausal and anticonceptives (G01-03) | 21 (9) | 48% | 0.823 |
Antirheumatic (L01, L04, M01-04) | 28 (12) | 39% | 0.550 |
Antiseizure, triptanes and central stimulating drugs (N02C, N03, N06B) | 20 (8) | 45% | 1.000 |
Chemotherapeutic drugs (L01-04) | 5 (2) | 60% | 0.660 |
Dermal drugs (D01-11, C05) | 14 (6) | 64% | 0.171 |
Drugs against urogenital and prostate disorders (G04) | 11 (5) | 55% | 0.551 |
Ocular drugs (S01) | 9 (4) | 44% | 1.000 |
Respiratory drugs (R01-05, 07, H02) | 20 (8) | 45% | 1.000 |
Sedatives and Antipsychotics (N05) | 39 (16) | 49% | 0.726 |
Strong analgesics (N02A, N07BC) | 3 (1) | 33% | 1.000 |
Thyroids and antithyroids (H03) | 26 (11) | 54% | 0.406 |
Vasodilators and cardiac glycosides (C01) | 5 (2) | 60% | 0.660 |
Other drugs total | 14 (6) | 57% | 0.413 |